Welcome to the Belgian Group of Digestive Oncology

The BGDO is an independent national group open to all physicians or researchers who have an interest in gastrointestinal oncology.

Join the BGDO

BGDO News

Upcoming events

🔹 16 September - 19:00  > BSMO webinar Radioligand Therapy in collaboration with the BGDO > go to details

🔹 20 November - 19:30  > BGDO Educational webinar  - Lower GI Cancers

🔹 17 January 2026  > BGDO Annual Meeting

🔹 24 & 25 April 2026  >BGDO Digestive Oncology Course

Replay BGDO Educational Webinar

🔹 PDAC and Esophagogastric Cancers >Replay

🔹 NET & HCC/Cholangioca: new developments and case discussions > Replay

Launch of the international SAFIR ABC10 program. The first precision medicine initiative for advanced biliary tract cancers, is now open for recruitment in the UK and France. Recruitment will also soon open in Belgium.> read press release

Reimbursement criteria for MOC/COM:

  • The DGEC / SECM (dienst voor geneeskundige evaluatie en controle / Service d'évaluation et de contrôle médicaux) has been working on the reimbursement criteria for MOC/COM.
    As a result, payments for several MOC/COM reports have been refused, especially in neuro-oncology but also for diverse reasons over all kinds of tumours. There has been a meeting with several actors on the field and DGEC has promised to send out a communication to the hospitals about the rules they apply for the moment. While we understand that rules are necessary and the budget has to be kept reasonable, we also believe that correct payment for valuable work is necessary. Therefore, a working group has been set up in order to work urgently on a new proposal for fair reimbursement of MOC/COM meetings.

The joint advice on screening for DPD-deficiency in patients treated with 5-FU, initiated by the Belgian Group of Digestive Oncology (BGDO) and endorsed by the Belgian Society of Medical Oncology (BSMO), College of Genetics (CG), Toxicological Society of Belgium and Luxembourg (BLT) has been published in ACTA CLINICA BELGICA. We all invite you to read the article. Go to the abstract 

BGDO Award 2025 - Congratulations to Frederik Peeters, UZ Leuven for his project on "Characterizing the antigenic landscape of hepatocellular carcinoma: implications for immunotherapy and individualized medicine"

BGDO DNET Award 2025 - Congratulations to Siddharth Chhajlani, UZA  for herproject on "RetroSAUNA, a retrospective study assessing the efficacy of continuation of somatostatin analogues upon progression in neuroendocrine tumour patients"

REACHIN trial: Results published in the Annals of Oncology on 24 May 2020
Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: a randomized, double-blind, phase 2 trial – REACHIN

BGDO TRIALS presented at ESMO and ASCO-GI Results of the MAGNET, QOLINPAC and REACH-IN trials are communicated in international congresses
MAGNET and QOLINPAC are accepted as poster and poster discussion at the forthcoming ESMO, and REACH-IN is sent as abstract for presentation at ASCO-GI.

The BGDO has been recognized legally as Sponsor for non-commercial clinical trials,which is a huge step forward for the implementation of new trials, and the development of the BGDO as a valid and reliable partner with other collaborative groups.

DNET Registry

The Digestive Neuroendocrine Tumor registry is a registry to collect epidemiological and medicinal data of patients suffering from digestive neuro-endocrine tumours via an electronic database.

On hold!

cancertrials.be

The cancertrials.be website is an initiative of the Belgian Society for Medical Oncology (BSMO). The aim of the website is to provide Belgian oncologists swift access to information on trial opportunities for their patients, with the possibility to directly contact one of the sites where the trial is open.

Search clinical trials

Mission statement

The Belgian group of Digestive Oncology (BGDO) is an independent non-profit, scientific, association open to all physicians or researchers who have an interest in gastrointestinal oncology.

It was created in 2003 and counts experts from different specialities, who are involved in GI cancer therapy.

The aims of the BGDO are

  • to improve the quality of care in GI oncology in a multidisciplinary way,
  • to enhance and promote teaching in the field of GI oncology by meetings and symposia,
  • to stimulate research in GI oncology
  • to develop protocols and guidelines for the benefit of patients and medical care,
  • to acitvely support and participate in national and international investigator driven clinical trails

For these purposes, the BGDO is collaborating with others national or international societies in order to work on common guidelines.